自噬
PTPN22型
磷酸化
吡喃结构域
生物
炎症体
蛋白质酪氨酸磷酸酶
细胞生物学
NALP3
分泌物
炎症
自身免疫
激酶
免疫学
基因
生物化学
细胞凋亡
免疫系统
单核苷酸多态性
基因型
作者
Marianne R. Spalinger,Silvia Lang,Claudia Gottier,Xuezhi Dai,David J. Rawlings,Andrew C. Chan,Gerhard Rogler,Michael Scharl
出处
期刊:Autophagy
[Taylor & Francis]
日期:2017-08-08
卷期号:13 (9): 1590-1601
被引量:121
标识
DOI:10.1080/15548627.2017.1341453
摘要
A variant within the gene locus encoding PTPN22 (protein tyrosine phosphatase, non-receptor type 22) emerged as an important risk factor for auto-inflammatory disorders, including rheumatoid arthritis, systemic lupus erythematosus and type 1 diabetes, but at the same time protects from Crohn disease, one of the 2 main forms of inflammatory bowel diseases. We have previously shown that loss of PTPN22 results in decreased NLRP3 (NLR family pyrin domain containing 3) activation and that this effect is mediated via enhanced NLRP3 phosphorylation. However, it is unclear how phosphorylation of NLRP3 mediates its inhibition. Here, we demonstrate that loss of macroautophagy/autophagy abrogates the inhibitory effect on NLRP3 activation observed upon loss of PTPN22. Phosphorylated, but not nonphosphorylated NLRP3 is found in autophagosomes, indicating that NLRP3 phosphorylation mediates its inactivation via promoting sequestration into phagophores, the precursors to autophagosomes. This finding shows that autophagy and NLRP3 inflammasome activation are connected, and that PTPN22 plays a key role in the regulation of those 2 pathways. Given its role in inflammatory disorders, PTPN22 might be an attractive therapeutic target, and understanding the cellular mechanisms modulated by PTPN22 is of crucial importance.
科研通智能强力驱动
Strongly Powered by AbleSci AI